| Product Code: ETC13369944 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Vaccine Contract Development and Manufacturing Organization Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Vaccine Contract Development and Manufacturing Organization Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Vaccine Contract Development and Manufacturing Organization Market - Industry Life Cycle |
3.4 Europe Vaccine Contract Development and Manufacturing Organization Market - Porter's Five Forces |
3.5 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.8 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Scale of Operation, 2021 & 2031F |
3.9 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Client Type, 2021 & 2031F |
3.10 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Technology Platform, 2021 & 2031F |
4 Europe Vaccine Contract Development and Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Vaccine Contract Development and Manufacturing Organization Market Trends |
6 Europe Vaccine Contract Development and Manufacturing Organization Market, 2021 - 2031 |
6.1 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Development Services, 2021 - 2031 |
6.1.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Manufacturing Services, 2021 - 2031 |
6.1.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By FillFinish Services, 2021 - 2031 |
6.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Viral Vector Vaccines, 2021 - 2031 |
6.2.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Subunit Vaccines, 2021 - 2031 |
6.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Clinical Scale, 2021 - 2031 |
6.3.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Commercial Scale, 2021 - 2031 |
6.3.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Pilot Scale, 2021 - 2031 |
6.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Government Agencies, 2020 - 2028 |
6.5 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By CellBased Platforms, 2020 - 2028 |
6.5.3 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Recombinant DNA Technology, 2020 - 2028 |
6.5.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By LiveAttenuated Platforms, 2020 - 2028 |
7 Europe Vaccine Contract Development and Manufacturing Organization Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Germany Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 France Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.4 Poland Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.5 Spain Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.6 Rest of Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 Europe Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3.2 Germany Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3.3 France Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3.4 Poland Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3.5 Spain Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3.6 Rest of Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.4 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.1 United Kingdom (UK) Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.2 Germany Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.3 France Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.4 Poland Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.5 Spain Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.4.6 Rest of Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Scale of Operation, 2021 - 2031 |
7.5 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.2 Germany Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.3 France Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.4 Poland Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.5 Spain Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.5.6 Rest of Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Client Type, 2021 - 2031 |
7.6 Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.1 United Kingdom (UK) Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.2 Germany Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.3 France Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.4 Poland Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.5 Spain Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
7.6.6 Rest of Europe Vaccine Contract Development and Manufacturing Organization Market, Revenues & Volume, By Technology Platform, 2021 - 2031 |
8 Europe Vaccine Contract Development and Manufacturing Organization Market Key Performance Indicators |
9 Europe Vaccine Contract Development and Manufacturing Organization Market - Export/Import By Countries Assessment |
10 Europe Vaccine Contract Development and Manufacturing Organization Market - Opportunity Assessment |
10.1 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.4 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Scale of Operation, 2021 & 2031F |
10.5 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Client Type, 2021 & 2031F |
10.6 Europe Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Technology Platform, 2021 & 2031F |
11 Europe Vaccine Contract Development and Manufacturing Organization Market - Competitive Landscape |
11.1 Europe Vaccine Contract Development and Manufacturing Organization Market Revenue Share, By Companies, 2022 |
11.2 Europe Vaccine Contract Development and Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here